Table 1.
Demographic characteristics in participants with abdominal obesity (AOPos) and without (AONeg).
[Mean (SD) or Number (%)].
Table 2.
Distribution of biochemistry examination and chronic diseases in participants with abdominal obesity (AOPos) and without (AONeg).
[Mean (SD) or Number (%)].
Table 3.
Adjusted ORs (95% CIs) of the prevalence of abdominal obesity by quintiles of the concentrations of the selected congeners (Men).
Table 4.
Adjusted ORs (95% CIs) of the prevalence of abdominal obesity by quintiles of the concentrations of the selected congeners (Women).
Fig 1.
Two-graph receiver operator characteristic (ROC) curves for HOMA-IR against serum PCDD/F levels.
These graphs indicate changes in sensitivity and specificity based on changes in the serum PCDD/F levels for (A) men and (B) women. Youden’s index (sensitivity + specificity − 1) is also shown. Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance.
Table 5.
Association between serum TEQDF-1998 and the risk of insulin resistance in participants (Men = 1466).
Table 6.
Association between serum TEQDF-1998 and the risk of insulin resistance in participants (Women = 1410).